BRIVANIB (B) IN ADVANCED OVARIAN CANCER (OC): SUBSET RESULTS OF A PHASE 2 RANDOMIZED DISCONTINUATION TRIAL (RDT)

被引：0

作者：

Kaye, S. B. ^{[1
,2
]}

Siu, L. L. ^{[3
]}

Jassem, J. ^{[4
]}

Medioni, J. ^{[5
]}

Soetekouw, P. M. M. B. ^{[6
]}

Slater, S. ^{[7
]}

Rudin, C. M. ^{[8
]}

Schwartz, G. K. ^{[9
]}

De Jonge, M. ^{[10
]}

O'Dwyer, P. ^{[11
]}

Baudelet, C. ^{[12
]}

Chen, A. ^{[13
]}

Ratain, M. J. ^{[14
]}

机构：

[1] Royal Marsden Hosp, Sutton, Surrey, England

[2] Inst Canc Res, Sutton, Surrey, England

[3] Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M4X 1K9, Canada

[4] Med Univ Gdansk, Gdansk, Poland

[5] Hop Europeen Georges Pompidou, Dept Med Oncol, Paris, France

[6] Maastricht Univ, Med Ctr, Div Med Oncol, Maastricht, Netherlands

[7] Beatson W Scotland Canc Ctr, Dept Med Oncol, Glasgow, Lanark, Scotland

[8] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[9] Mem Sloan Kettering Canc Ctr, Melanoma & Sarcoma Serv, New York, NY 10021 USA

[10] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands

[11] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[12] Brstol Myers Squibb, Res & Dev, Braine Lalleud, Belgium

[13] Bristol Myers Squibb Co, Res & Dev, Wallingford, CT 06492 USA

[14] Univ Chicago, Dept Med, Chicago, IL 60637 USA

来源：

ANNALS OF ONCOLOGY | 2012年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：319 / 319

页数：1

共 50 条

[41] Disparate US and Canadian results in trial of antibody for advanced ovarian cancer [J].

不详 .

BIOTECHNOLOGY LAW REPORT, 2002, 21 (04) :342-343

[42] Final findings from a phase II, placebo-controlled, randomized discontinuation trial (RDT) of sorafenib (BAY 43-9006) in patients with advanced renal cell carcinoma (RCC). [J].

Ratain, MJ ;

Eisen, T ;

Stadler, WM ;

Flaherty, KT ;

Gore, M ;

Desai, A ;

Patnaik, A ;

Xiong, HQ ;

Schwartz, B ;

O'Dwyer, P .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :388S-388S

[43] Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial [J].

Partridge, Edward ;

Kreimer, Aimee R. ;

Greenlee, Robert T. ;

Williams, Craig ;

Xu, Jian-Lun ;

Church, Timothy R. ;

Kessel, Bruce ;

Johnson, Christine C. ;

Weissfeld, Joel L. ;

Isaacs, Claudine ;

Andriole, Gerald L. ;

Ogden, Sheryl ;

Ragard, Lawrence R. ;

Buys, Saundra S. .

OBSTETRICS AND GYNECOLOGY, 2009, 113 (04) :775-782

[44] Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancer [J].

Campos, S ;

Hamid, C ;

Seiden, MV ;

Oza, A ;

Plante, M ;

Potkul, RK ;

Lenehan, PF ;

Kaldjian, EP ;

Varterasian, ML ;

Jordan, C ;

Charbonneau, C ;

Hirte, H .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5597-5604

[45] First results of the PETACC-6 randomized phase III trial in locally advanced rectal cancer [J].

Haustermans, K. ;

Schmoll, H. J. ;

Price, T. ;

Nordlinger, B. ;

Hofheinz, R. D. ;

Daisne, J. F. ;

Janssens, J. ;

Schmidt, P. ;

Reinel, H. ;

Van Cutsem, E. .

RADIOTHERAPY AND ONCOLOGY, 2014, 111 :S96-S96

[46] Carbogen and nicotinamide in locally advanced bladder cancer: Early results of a phase-III randomized trial [J].

Hoskin, Peter J. ;

Rojas, Ana M. ;

Saunders, Michele I. ;

Bentzen, S. M. ;

Motohashi, K. J. .

RADIOTHERAPY AND ONCOLOGY, 2009, 91 (01) :120-125

[47] HER2 overexpression and amplification in advanced ovarian cancer (OC):: Preliminary results from a large GINECO study. [J].

Camilleri-Broët, S ;

Guastalla, JP ;

Couturier, J ;

Curé, H ;

Penault-Llorca, F ;

Allouache, D ;

Vincent-Salomon, A ;

Paraïso, D ;

Pujade-Lauraine, E .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :469S-469S

[48] Induction Chemotherapy in Locally Advanced Pancreatic Cancer (LAPC) - Final Results of a Multicenter Randomized Phase 2 AIO Trial (NEOLAP) [J].

Hartlapp, Ingo ;

Alguel, Hana ;

Goekkurt, Eray ;

Siegler, Gabriele ;

Martens, Uwe ;

Waldschmidt, Dirk ;

Pelzer, Uwe ;

Hennes, Elke ;

Fuchs, Martin ;

Siveke, Jens ;

Kullmann, Frank ;

Boeck, Stefan ;

Ettrich, Thomas J. ;

Ferenczy, Peter ;

Keller, Ralph ;

Germer, Christoph-Thomas ;

Stein, Hubert ;

Klein, Ingo ;

Heinemann, Volker ;

Kunzmann, Volker .

ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 :63-63

[49] KEYNOTE-100: Phase 2 trial of pembrolizumab in patients with advanced recurrent ovarian cancer [J].

Matulonis, U. A. ;

Chen, M. ;

Puhlmann, M. ;

Shentu, Y. ;

Ledermann, J. .

ANNALS OF ONCOLOGY, 2016, 27

[50] Preliminary results from a Phase II trial of EPO906 patients with advanced refractory ovarian cancer [J].

Kaye, S ;

Oza, A ;

Gore, M ;

Huinink, W ;

Smit, W ;

Gibbon, D ;

Miller, W ;

Mull, R ;

Chitale, K ;

Rothermel, J .

EUROPEAN JOURNAL OF CANCER, 2002, 38 :S43-S43

← 1 2 3 4 5 →